Cargando…

Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels

All mammals lose their ability to produce lactase (β-galactosidase), the enzyme that cleaves lactose into galactose and glucose, after weaning. The prevalence of lactase deficiency (LD) spans from 2 to 15% among northern Europeans, to nearly 100% among Asians. Following lactose consumption, people w...

Descripción completa

Detalles Bibliográficos
Autores principales: Estévez, César A, Isasi, José Ramón, Larrañeta, Eneko, Vélaz, Itziar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311648/
https://www.ncbi.nlm.nih.gov/pubmed/25670982
http://dx.doi.org/10.3762/bjoc.10.330
_version_ 1782355033706201088
author Estévez, César A
Isasi, José Ramón
Larrañeta, Eneko
Vélaz, Itziar
author_facet Estévez, César A
Isasi, José Ramón
Larrañeta, Eneko
Vélaz, Itziar
author_sort Estévez, César A
collection PubMed
description All mammals lose their ability to produce lactase (β-galactosidase), the enzyme that cleaves lactose into galactose and glucose, after weaning. The prevalence of lactase deficiency (LD) spans from 2 to 15% among northern Europeans, to nearly 100% among Asians. Following lactose consumption, people with LD often experience gastrointestinal symptoms such as abdominal pain, bowel distension, cramps and flatulence, or even systemic problems such as headache, loss of concentration and muscle pain. These symptoms vary depending on the amount of lactose ingested, type of food and degree of intolerance. Although those affected can avoid the uptake of dairy products, in doing so, they lose a readily available source of calcium and protein. In this work, gels obtained by complexation of Tetronic 90R4 with α-cyclodextrin loaded with β-galactosidase are proposed as a way to administer the enzyme immediately before or with the lactose-containing meal. Both molecules are biocompatible, can form gels in situ, and show sustained erosion kinetics in aqueous media. The complex was characterized by FTIR that evidenced an inclusion complex between the polyethylene oxide block and α-cyclodextrin. The release profiles of β-galactosidase from two different matrices (gels and tablets) of the in situ hydrogels have been obtained. The influence of the percentage of Tetronic in media of different pH was evaluated. No differences were observed regarding the release rate from the gel matrices at pH 6 (t(50) = 105 min). However, in the case of the tablets, the kinetics were faster and they released a greater amount of 90R4 (25%, t(50) = 40–50 min). Also, the amount of enzyme released was higher for mixtures with 25% Tetronic. Using suitable mathematical models, the corresponding kinetic parameters have been calculated. In all cases, the release data fit quite well to the Peppas–Sahlin model equation, indicating that the release of β-galactosidase is governed by a combination of diffusion and erosion processes. It has been observed that the diffusion mechanism prevails over erosion during the first 50 minutes, followed by continued release of the enzyme due to the disintegration of the matrix.
format Online
Article
Text
id pubmed-4311648
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Beilstein-Institut
record_format MEDLINE/PubMed
spelling pubmed-43116482015-02-10 Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels Estévez, César A Isasi, José Ramón Larrañeta, Eneko Vélaz, Itziar Beilstein J Org Chem Full Research Paper All mammals lose their ability to produce lactase (β-galactosidase), the enzyme that cleaves lactose into galactose and glucose, after weaning. The prevalence of lactase deficiency (LD) spans from 2 to 15% among northern Europeans, to nearly 100% among Asians. Following lactose consumption, people with LD often experience gastrointestinal symptoms such as abdominal pain, bowel distension, cramps and flatulence, or even systemic problems such as headache, loss of concentration and muscle pain. These symptoms vary depending on the amount of lactose ingested, type of food and degree of intolerance. Although those affected can avoid the uptake of dairy products, in doing so, they lose a readily available source of calcium and protein. In this work, gels obtained by complexation of Tetronic 90R4 with α-cyclodextrin loaded with β-galactosidase are proposed as a way to administer the enzyme immediately before or with the lactose-containing meal. Both molecules are biocompatible, can form gels in situ, and show sustained erosion kinetics in aqueous media. The complex was characterized by FTIR that evidenced an inclusion complex between the polyethylene oxide block and α-cyclodextrin. The release profiles of β-galactosidase from two different matrices (gels and tablets) of the in situ hydrogels have been obtained. The influence of the percentage of Tetronic in media of different pH was evaluated. No differences were observed regarding the release rate from the gel matrices at pH 6 (t(50) = 105 min). However, in the case of the tablets, the kinetics were faster and they released a greater amount of 90R4 (25%, t(50) = 40–50 min). Also, the amount of enzyme released was higher for mixtures with 25% Tetronic. Using suitable mathematical models, the corresponding kinetic parameters have been calculated. In all cases, the release data fit quite well to the Peppas–Sahlin model equation, indicating that the release of β-galactosidase is governed by a combination of diffusion and erosion processes. It has been observed that the diffusion mechanism prevails over erosion during the first 50 minutes, followed by continued release of the enzyme due to the disintegration of the matrix. Beilstein-Institut 2014-12-24 /pmc/articles/PMC4311648/ /pubmed/25670982 http://dx.doi.org/10.3762/bjoc.10.330 Text en Copyright © 2014, Estévez et al. https://creativecommons.org/licenses/by/2.0https://www.beilstein-journals.org/bjoc/termsThis is an Open Access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (https://www.beilstein-journals.org/bjoc/terms)
spellingShingle Full Research Paper
Estévez, César A
Isasi, José Ramón
Larrañeta, Eneko
Vélaz, Itziar
Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
title Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
title_full Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
title_fullStr Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
title_full_unstemmed Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
title_short Release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
title_sort release of β-galactosidase from poloxamine/α-cyclodextrin hydrogels
topic Full Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311648/
https://www.ncbi.nlm.nih.gov/pubmed/25670982
http://dx.doi.org/10.3762/bjoc.10.330
work_keys_str_mv AT estevezcesara releaseofbgalactosidasefrompoloxamineacyclodextrinhydrogels
AT isasijoseramon releaseofbgalactosidasefrompoloxamineacyclodextrinhydrogels
AT larranetaeneko releaseofbgalactosidasefrompoloxamineacyclodextrinhydrogels
AT velazitziar releaseofbgalactosidasefrompoloxamineacyclodextrinhydrogels